(-)-O- Desmethyl Tramadol

METABOLITES

Product Details

CAT No.# CS-O-31051
Category Metabolites
CAS 144830-15-9
Molecular Weight 249.35
Molecular Formula C15H23NO2
Stock Status: In-Stock
Purity: >98%
Synonyms: ;3-[(1S,2S)-2-[(dimethylamino)methyl]-1-hydrylamino)methyl]-1-(3-hydroxyphen;3-[(1S,2S)-2-[(dimethylamino)methyl]-1-hydrylamino)methyl]-1-(3-hydroxyphenT; (-)-O-Demethyltramadol;
Application Notes: A optically active metabolite of Tramadol.
References: Lintz, V.W., et al.: Arzneim.-Forsch./Drug Res., 31, II, 11, 1932 (1981)
Shipping: Free Shipping for worldwide on order above 2000 USD
COA / MSDS:    View COA    MSDS
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
(-)-O- Desmethyl Tramadol Worldwide Suppliers of (-)-O- Desmethyl Tramadol Metabolites Clearsynth CS-O-31051

Product rating: 9 (-)-O- Desmethyl Tramadol based on 20 ratings

  1. Metabolites
  2. (-)-O- Desmethyl Tramadol
PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. tibolone (848)
11. (Z)-Dimethylvinphos
12. Silodosin Metabolite
13. 2-Phenoxymethanesulfonanilide
14. Nimesulide EP Impurity A
15. Acetone HPLC
16. Nandrolone Decanoate EP impurity F
17. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline
18. Thyroxamine
19. Ortho toluene sulfonic acid
20. Sucrose (1623637)


Smileys:
O[C@](CCCC1)(C2=CC(O)=CC=C2)[C@@H]1CN(C)C



This page contains information about (-)-O- Desmethyl Tramadol Cas 144830-15-9 and its Metabolites.

(-)-O- Desmethyl Tramadol (-)-O- Desmethyl Tramadol Metabolites of (-)-O- Desmethyl Tramadol Metabolites Clearsynth 144830-15-9 https://www.clearsynth.com/en/temp/CS-O-31051.jpg

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."